Can you take Folic acid with Ultrase MT 18?
1 drug interaction and 5 additional warnings found for the following 2 drugs:
- folic acid
- Ultrase MT 18 (pancrelipase)
Drug interactions
Moderate drug interactions
Moderate:
folic acid pancrelipase
Applies to: folic acid and Ultrase MT 18 (pancrelipase)
Pancrelipase may reduce the effectiveness of folic acid and iron by interfering with their absorption. To prevent or minimize the interaction, you should separate the dosing times of pancrelipase and any product containing folic acid or iron by as much as possible. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
Moderate food/lifestyle interactions
Moderate:
folic acid Food/Lifestyle
Applies to: folic acid
Talk to your doctor before using alcohol together with folic acid. Excessive consumption of alcohol may reduce the absorption and increase the elimination of folic acid. Contact your doctor if your symptoms worsen or your condition changes. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Moderate:
pancrelipase multivitamins with minerals
Applies to: Ultrase MT 18 (pancrelipase)
Pancrelipase may reduce the effectiveness of folic acid and iron by interfering with their absorption. To prevent or minimize the interaction, you should separate the dosing times of pancrelipase and any product containing folic acid or iron by as much as possible. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Disease interactions
3 potential interactions Applies to: 3 conditions, including Gout, Renal Dysfunction, and Anemia of Unspecified Nutritional Deficiency.
Anemia of Unspecified Nutritional Deficiency
Major:
folic acid
Folic acid has a major potential interaction with Anemia of Unspecified Nutritional Deficiency.
The use of folic acid is contraindicated in patients with undiagnosed anemia. Folic acid in dosages above 1 mg/day can obscure the diagnosis of pernicious anemia by alleviating the hematologic abnormalities while allowing the progression of neurologic complications. In addition, folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Gout
Moderate:
Ultrase MT 18
The pancrelipase in Ultrase MT 18 has a moderate potential interaction with Gout.
Porcine-derived pancreatic enzyme products contain purines that may increase blood uric acid levels. Extremely high dosages of exogenous pancreatic enzymes have also been associated with hyperuricosuria and hyperuricemia. Therapy with pancrelipase should be administered cautiously in patients with preexisting hyperuricemia, gout, or renal impairment. Monitoring of serum uric acid levels is recommended.
Renal Dysfunction
Moderate:
Ultrase MT 18
The pancrelipase in Ultrase MT 18 has a moderate potential interaction with Renal Dysfunction.
Porcine-derived pancreatic enzyme products contain purines that may increase blood uric acid levels. Extremely high dosages of exogenous pancreatic enzymes have also been associated with hyperuricosuria and hyperuricemia. Therapy with pancrelipase should be administered cautiously in patients with preexisting hyperuricemia, gout, or renal impairment. Monitoring of serum uric acid levels is recommended.
Report options
More resources
folic acid
A total of 35 drugs are known to interact with folic acid.
- Folic acid is in the drug class vitamins.
- Folic acid is used to treat the following conditions:
Ultrase MT 18
A total of 26 drugs are known to interact with Ultrase MT 18.
- Ultrase mt 18 is in the drug class digestive enzymes.
- Ultrase mt 18 is used to treat the following conditions:
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.